pan-KRAS inhibitor PF-07934040
Term · Oncology and biomedicine · MLC-T-ONC-015798
An orally bioavailable inhibitor of KRAS mutations, with potential antineoplastic activity. Upon oral administration, pan-KRAS inhibitor PF-07934040 targets, binds to and inhibits various forms of KRAS mutations, thereby inhibiting KRAS-dependent signaling. This inhibits the proliferation of and induces apoptosis in tumor cells in which KRAS is mutated. KRAS plays an important role in cell signaling, division and differentiation. Mutations of KRAS may induce constitutive signal transduction leading to tumor cell growth, proliferation, invasion, and metastasis.
| Identifier | MLC-T-ONC-015798 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | KRAS inhibitor PF-07934040; pan-KRAS mutant inhibitor PF-07934040 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015798",
"term": "pan-KRAS inhibitor PF-07934040",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable inhibitor of KRAS mutations, with potential antineoplastic activity. Upon oral administration, pan-KRAS inhibitor PF-07934040 targets, binds to and inhibits various forms of KRAS mutations, thereby inhibiting KRAS-dependent signaling. This inhibits the proliferation of and induces apoptosis in tumor cells in which KRAS is mutated. KRAS plays an important role in cell signaling, division and differentiation. Mutations of KRAS may induce constitutive signal transduction leading to tumor cell growth, proliferation, invasion, and metastasis.",
"synonyms": [
"KRAS inhibitor PF-07934040",
"pan-KRAS mutant inhibitor PF-07934040"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/pan-kras-inhibitor-pf-07934040/"
}
Record 12,591 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.